Home Cart 0 Sign in  
X

[ CAS No. 2215-77-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 2215-77-2
Chemical Structure| 2215-77-2
Chemical Structure| 2215-77-2
Structure of 2215-77-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 2215-77-2 ]

Related Doc. of [ 2215-77-2 ]

Alternatived Products of [ 2215-77-2 ]

Product Details of [ 2215-77-2 ]

CAS No. :2215-77-2 MDL No. :MFCD00002539
Formula : C13H10O3 Boiling Point : -
Linear Structure Formula :- InChI Key :RYAQFHLUEMJOMF-UHFFFAOYSA-N
M.W : 214.22 Pubchem ID :75182
Synonyms :

Calculated chemistry of [ 2215-77-2 ]

Physicochemical Properties

Num. heavy atoms : 16
Num. arom. heavy atoms : 12
Fraction Csp3 : 0.0
Num. rotatable bonds : 3
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 59.92
TPSA : 46.53 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -4.83 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.08
Log Po/w (XLOGP3) : 3.91
Log Po/w (WLOGP) : 3.18
Log Po/w (MLOGP) : 2.81
Log Po/w (SILICOS-IT) : 2.43
Consensus Log Po/w : 2.88

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -3.99
Solubility : 0.022 mg/ml ; 0.000103 mol/l
Class : Soluble
Log S (Ali) : -4.59
Solubility : 0.00556 mg/ml ; 0.000026 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -4.04
Solubility : 0.0198 mg/ml ; 0.0000923 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 1.46

Safety of [ 2215-77-2 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 2215-77-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 2215-77-2 ]
  • Downstream synthetic route of [ 2215-77-2 ]

[ 2215-77-2 ] Synthesis Path-Upstream   1~3

  • 1
  • [ 2215-77-2 ]
  • [ 107622-80-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2009, vol. 17, # 4, p. 1428 - 1436
  • 2
  • [ 2215-77-2 ]
  • [ 330792-69-3 ]
Reference: [1] Patent: WO2013/10136, 2013, A2,
[2] Patent: US2013/178483, 2013, A1,
[3] Patent: WO2014/68527, 2014, A1,
[4] Patent: WO2014/68527, 2014, A1,
[5] Patent: WO2014/82598, 2014, A1,
[6] Patent: WO2014/173289, 2014, A1,
[7] Patent: US2015/5277, 2015, A1,
[8] Patent: US9107924, 2015, B2,
[9] Patent: WO2015/181633, 2015, A2,
[10] Patent: WO2015/185998, 2015, A2,
[11] Patent: WO2016/24227, 2016, A1,
[12] Patent: WO2016/24232, 2016, A1,
[13] Patent: WO2016/24230, 2016, A1,
[14] Patent: WO2016/20901, 2016, A1,
[15] Patent: WO2016/170545, 2016, A1,
[16] Patent: EP3141546, 2017, A1,
[17] Patent: WO2017/46747, 2017, A1,
[18] Patent: US2017/35881, 2017, A1,
[19] Patent: WO2017/137446, 2017, A1,
[20] Patent: WO2017/163257, 2017, A1,
[21] Patent: CN107652294, 2018, A,
[22] Patent: WO2018/33135, 2018, A1,
[23] Patent: TWI602818, 2017, B,
[24] Patent: TW2018/11794, 2018, A,
[25] Patent: WO2018/137681, 2018, A1,
[26] Patent: US2018/318304, 2018, A1,
  • 3
  • [ 2215-77-2 ]
  • [ 1022150-11-3 ]
Reference: [1] Patent: WO2016/170545, 2016, A1,
[2] Patent: CN106188062, 2016, A,
[3] Patent: WO2017/137446, 2017, A1,
[4] Patent: WO2017/163257, 2017, A1,
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 2215-77-2 ]

Ibrutinib Related Intermediates

Chemical Structure| 51067-38-0

[ 51067-38-0 ]

(4-Phenoxyphenyl)boronic acid

Chemical Structure| 1022150-11-3

[ 1022150-11-3 ]

(R)-tert-Butyl 3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate

Chemical Structure| 2380-63-4

[ 2380-63-4 ]

1H-Pyrazolo[3,4-d]pyrimidin-4-amine

Chemical Structure| 330786-24-8

[ 330786-24-8 ]

3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Chemical Structure| 151266-23-8

[ 151266-23-8 ]

3-Iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Related Functional Groups of
[ 2215-77-2 ]

Aryls

Chemical Structure| 3739-38-6

[ 3739-38-6 ]

3-Phenoxybenzoic acid

Similarity: 0.98

Chemical Structure| 13205-47-5

[ 13205-47-5 ]

4-(tert-Butoxy)benzoic acid

Similarity: 0.96

Chemical Structure| 1486-51-7

[ 1486-51-7 ]

4-(Benzyloxy)benzoic acid

Similarity: 0.96

Chemical Structure| 78303-09-0

[ 78303-09-0 ]

Methyl 3-(p-tolyloxy)benzoate

Similarity: 0.94

Chemical Structure| 100-09-4

[ 100-09-4 ]

4-Methoxybenzoic acid

Similarity: 0.93

Ethers

Chemical Structure| 3739-38-6

[ 3739-38-6 ]

3-Phenoxybenzoic acid

Similarity: 0.98

Chemical Structure| 13205-47-5

[ 13205-47-5 ]

4-(tert-Butoxy)benzoic acid

Similarity: 0.96

Chemical Structure| 1486-51-7

[ 1486-51-7 ]

4-(Benzyloxy)benzoic acid

Similarity: 0.96

Chemical Structure| 78303-09-0

[ 78303-09-0 ]

Methyl 3-(p-tolyloxy)benzoate

Similarity: 0.94

Chemical Structure| 100-09-4

[ 100-09-4 ]

4-Methoxybenzoic acid

Similarity: 0.93

Carboxylic Acids

Chemical Structure| 3739-38-6

[ 3739-38-6 ]

3-Phenoxybenzoic acid

Similarity: 0.98

Chemical Structure| 13205-47-5

[ 13205-47-5 ]

4-(tert-Butoxy)benzoic acid

Similarity: 0.96

Chemical Structure| 1486-51-7

[ 1486-51-7 ]

4-(Benzyloxy)benzoic acid

Similarity: 0.96

Chemical Structure| 100-09-4

[ 100-09-4 ]

4-Methoxybenzoic acid

Similarity: 0.93

Chemical Structure| 30762-06-2

[ 30762-06-2 ]

4-Phenethoxybenzoic acid

Similarity: 0.92